The microbiome: A target for Alzheimer disease?

TY - JOUR

T1 - The microbiome

T2 - A target for Alzheimer disease?

AU - Seo, Dong oh

AU - Boros, Benjamin D.

AU - Holtzman, David M.

N1 - Funding Information: Competing interests: David M. Holtzman is a co-founder of C2N Diagnostics LLC. He is on the scientific advisory board of Genentech, Denali, and C2N Diagnostics. He consults for Idorsia. His lab receives research grants from the National Institutes of Health, Cure Alzheimer’s Fund, Tau Consortium, the JPB Foundation, and C2N Diagnostics.

PY - 2019/10/1

Y1 - 2019/10/1

UR - http://www.scopus.com/inward/record.url?scp=85072905140&partnerID=8YFLogxK

U2 - 10.1038/s41422-019-0227-7

DO - 10.1038/s41422-019-0227-7

M3 - Article

C2 - 31488883

AN - SCOPUS:85072905140

SN - 1001-0602

VL - 29

SP - 779

EP - 780

JO - Cell Research

JF - Cell Research

IS - 10

ER -